학술논문

Does molecular scarring in psoriasis exist? A review of the literature.
Document Type
Article
Source
Advances in Dermatology & Allergology / Postępy Dermatologii i Alergologii. Aug2023, Vol. 40 Issue 4, p473-480. 8p.
Subject
*PSORIASIS
*CHRONIC inflammatory demyelinating polyradiculoneuropathy
*CYTOKINES
*INTERLEUKINS
*EPIDERMIS
Language
ISSN
1642-395X
Abstract
Plaque psoriasis is a chronic inflammatory dermatosis characterized by a tendency to recur in the same locations after discontinuation of treatment. The implementation of therapy with drugs targeting cytokines like interleukin (IL) 17A (IL-17A) and IL-23 has revolutionized the treatment of psoriasis and enabled the achievement of skin without lesions. However, despite the clinical resolution of psoriatic eruptions, cells that maintain the local memory of the disease remain in the dermis and epidermis, constituting a kind of molecular scar. The cells responsible for maintaining memory in the skin of patients and influencing the rapid relapse of the disease after the triggering factor are primarily tissue resident memory T cells (TRM), but it seems that regulatory T lymphocytes (Treg), dendritic cells (DC), and Langerhans cells (LC) may also play an important role in this process. We reviewed the literature to explain the concept of molecular scarring in psoriasis, and to assess the effect of various therapies on immune memory. [ABSTRACT FROM AUTHOR]